Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | DOI[10.1038/nbt.2488] | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | urine |
PMID[9129323] |
||
NPO20338 | Mus musculus | Species | Muridae | Eukaryota |
PMID[19425150] |
|||
NPO21658 | Saccharomyces cerevisiae | Species | Saccharomycetaceae | Eukaryota |
PMID[24678285] |
|||
NPO4011 | Chlamydomonas reinhardtii | Species | Chlamydomonadaceae | Eukaryota |
PMID[25515814] |
|||
NPO730 | Escherichia coli | Species | Enterobacteriaceae | Bacteria |
PMID[21988831] |
|||
NPO8874 | Glehnia littoralis | Species | Apiaceae | Eukaryota | TM-MC* | |||
NPO19048 | Pinellia ternata | Species | Araceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 150 | nM | 15084123 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 240 | nM | 15084123 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 210 | nM | 15084123 |
NPT1316 | Individual Protein | Adenosine A2a receptor | Rattus norvegicus | Ki | = | 1130 | nM | 15084123 |
NPT1316 | Individual Protein | Adenosine A2a receptor | Rattus norvegicus | Ki | = | 1180 | nM | 15084123 |
NPT4059 | Individual Protein | Adenosine A2b receptor | Homo sapiens | Ki | = | 13900 | nM | 15084123 |
NPT4059 | Individual Protein | Adenosine A2b receptor | Homo sapiens | Ki | = | 8200 | nM | 15084123 |
NPT218 | Individual Protein | Adenosine A3 receptor | Homo sapiens | Ki | = | 680 | nM | 15084123 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | IC50 | = | 680 | nM | 15084123 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | IC50 | = | 15100 | nM | 15084123 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ratio | = | 22.2 | 15084123 | |
NPT218 | Individual Protein | Adenosine A3 receptor | Homo sapiens | IC50 | = | 71000 | nM | 15084123 |
NPT4545 | Individual Protein | Indolethylamine N-methyltransferase | Homo sapiens | Ki | = | 700000 | nM | 6620306 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 600000 | nM | 2496231 |
NPT1864 | Cell Line | L5178Y | Mus musculus | IC50 | = | 60000 | nM | 2496231 |
NPT137 | Cell Line | L1210 | Mus musculus | Activity | = | 3.64 | nM (10e6*cells)-1 | 2496231 |
NPT137 | Cell Line | L1210 | Mus musculus | Activity | = | 1.59 | nM (10e6*cells)-1 | 2496231 |
NPT137 | Cell Line | L1210 | Mus musculus | Activity | = | 0.2 | nM (10e6*cells)-1 | 2496231 |
NPT1864 | Cell Line | L5178Y | Mus musculus | Activity | = | 1.24 | nM (10e6*cells)-1 | 2496231 |
NPT1864 | Cell Line | L5178Y | Mus musculus | Activity | = | 3.03 | nM (10e6*cells)-1 | 2496231 |
NPT1864 | Cell Line | L5178Y | Mus musculus | Activity | = | 0.47 | nM (10e6*cells)-1 | 2496231 |
NPT4546 | Individual Protein | Catechol O-methyltransferase | Homo sapiens | Ki | > | 5400000 | nM | 7310802 |
NPT865 | Individual Protein | Fatty acid synthase | Homo sapiens | Ki | = | 1500000 | nM | 15026045 |
NPT4547 | Individual Protein | Spermidine synthase | Rattus norvegicus | Activity | = | 44 | % | 7241513 |
NPT4547 | Individual Protein | Spermidine synthase | Rattus norvegicus | Activity | = | 12 | % | 7241513 |
NPT4547 | Individual Protein | Spermidine synthase | Rattus norvegicus | Activity | = | 41 | % | 7241513 |
NPT4547 | Individual Protein | Spermidine synthase | Rattus norvegicus | Activity | = | 9 | % | 7241513 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 850000 | nM | 1908523 |
NPT1864 | Cell Line | L5178Y | Mus musculus | IC50 | = | 200000 | nM | 1908523 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | IC50 | = | 150000 | nM | 1908523 |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | IC50 | = | 11000 | nM | 1908523 |
NPT137 | Cell Line | L1210 | Mus musculus | Activity | = | 1.93 | 1908523 | |
NPT137 | Cell Line | L1210 | Mus musculus | Activity | = | 1.22 | 1908523 | |
NPT137 | Cell Line | L1210 | Mus musculus | Activity | = | 0.19 | 1908523 | |
NPT1864 | Cell Line | L5178Y | Mus musculus | Activity | = | 1.85 | 1908523 | |
NPT1864 | Cell Line | L5178Y | Mus musculus | Activity | = | 2.79 | 1908523 | |
NPT1864 | Cell Line | L5178Y | Mus musculus | Activity | = | 0.43 | 1908523 | |
NPT912 | Individual Protein | Adenosylhomocysteinase | Homo sapiens | Activity | = | 101 | % | 1908523 |
NPT912 | Individual Protein | Adenosylhomocysteinase | Homo sapiens | Activity | = | 94 | % | 1908523 |
NPT912 | Individual Protein | Adenosylhomocysteinase | Homo sapiens | Activity | = | 86 | % | 1908523 |
NPT912 | Individual Protein | Adenosylhomocysteinase | Homo sapiens | Activity | = | 66 | % | 1908523 |
NPT912 | Individual Protein | Adenosylhomocysteinase | Homo sapiens | Activity | = | 48 | % | 1908523 |
NPT4549 | Individual Protein | S-methyl-5-thioadenosine phosphorylase | Homo sapiens | Ratio | = | 0.0001 | 1/uM*sec | 15911263 |
NPT4549 | Individual Protein | S-methyl-5-thioadenosine phosphorylase | Homo sapiens | Ratio | = | 3.2 | 1/uM*sec | 15911263 |
NPT4551 | Individual Protein | Spermidine synthase | Plasmodium falciparum | IC50 | = | 159000 | nM | 18410081 |
NPT471 | Organism | Trypanosoma brucei brucei | Trypanosoma brucei brucei | IC50 | = | 100000 | nM | 17954686 |
NPT2 | Others | Unspecified | Activity | = | 100 | % | 17954686 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC136349 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9643 | High Similarity | NPC328479 |
0.9444 | High Similarity | NPC195140 |
0.9412 | High Similarity | NPC317821 |
0.9078 | High Similarity | NPC189068 |
0.9067 | High Similarity | NPC325906 |
0.9014 | High Similarity | NPC309832 |
0.9014 | High Similarity | NPC219313 |
0.9007 | High Similarity | NPC156461 |
0.9007 | High Similarity | NPC107374 |
0.9007 | High Similarity | NPC21448 |
0.9 | High Similarity | NPC229974 |
0.9 | High Similarity | NPC324484 |
0.8993 | High Similarity | NPC161659 |
0.8993 | High Similarity | NPC209525 |
0.8944 | High Similarity | NPC164665 |
0.8881 | High Similarity | NPC269827 |
0.8865 | High Similarity | NPC314152 |
0.8786 | High Similarity | NPC129756 |
0.8707 | High Similarity | NPC472816 |
0.8639 | High Similarity | NPC211025 |
0.8639 | High Similarity | NPC185991 |
0.8639 | High Similarity | NPC85689 |
0.8581 | High Similarity | NPC321814 |
0.8562 | High Similarity | NPC121222 |
0.8523 | High Similarity | NPC212551 |
0.8523 | High Similarity | NPC130586 |
0.8523 | High Similarity | NPC302778 |
0.8523 | High Similarity | NPC164952 |
0.8477 | Intermediate Similarity | NPC316618 |
0.8477 | Intermediate Similarity | NPC239737 |
0.8467 | Intermediate Similarity | NPC174802 |
0.8451 | Intermediate Similarity | NPC33996 |
0.8446 | Intermediate Similarity | NPC150853 |
0.8411 | Intermediate Similarity | NPC224076 |
0.8389 | Intermediate Similarity | NPC161224 |
0.8355 | Intermediate Similarity | NPC226245 |
0.8333 | Intermediate Similarity | NPC207633 |
0.8313 | Intermediate Similarity | NPC189261 |
0.817 | Intermediate Similarity | NPC52238 |
0.8117 | Intermediate Similarity | NPC311197 |
0.8117 | Intermediate Similarity | NPC313754 |
0.8117 | Intermediate Similarity | NPC54320 |
0.8089 | Intermediate Similarity | NPC323091 |
0.8056 | Intermediate Similarity | NPC320818 |
0.7888 | Intermediate Similarity | NPC290959 |
0.7771 | Intermediate Similarity | NPC93365 |
0.7764 | Intermediate Similarity | NPC261595 |
0.7716 | Intermediate Similarity | NPC324033 |
0.7716 | Intermediate Similarity | NPC321458 |
0.7697 | Intermediate Similarity | NPC326529 |
0.7669 | Intermediate Similarity | NPC326082 |
0.7651 | Intermediate Similarity | NPC324198 |
0.7651 | Intermediate Similarity | NPC319100 |
0.75 | Intermediate Similarity | NPC262926 |
0.745 | Intermediate Similarity | NPC61198 |
0.7405 | Intermediate Similarity | NPC321052 |
0.7384 | Intermediate Similarity | NPC24589 |
0.7381 | Intermediate Similarity | NPC313897 |
0.7356 | Intermediate Similarity | NPC282458 |
0.7356 | Intermediate Similarity | NPC78941 |
0.7347 | Intermediate Similarity | NPC104011 |
0.7248 | Intermediate Similarity | NPC324009 |
0.7237 | Intermediate Similarity | NPC30326 |
0.7208 | Intermediate Similarity | NPC186619 |
0.72 | Intermediate Similarity | NPC319221 |
0.7179 | Intermediate Similarity | NPC89147 |
0.7179 | Intermediate Similarity | NPC274384 |
0.7115 | Intermediate Similarity | NPC318590 |
0.7115 | Intermediate Similarity | NPC211820 |
0.7115 | Intermediate Similarity | NPC251233 |
0.707 | Intermediate Similarity | NPC177169 |
0.707 | Intermediate Similarity | NPC317746 |
0.7051 | Intermediate Similarity | NPC315642 |
0.7051 | Intermediate Similarity | NPC74306 |
0.7025 | Intermediate Similarity | NPC64705 |
0.7025 | Intermediate Similarity | NPC232408 |
0.6966 | Remote Similarity | NPC313514 |
0.6957 | Remote Similarity | NPC326694 |
0.6934 | Remote Similarity | NPC476564 |
0.6908 | Remote Similarity | NPC57279 |
0.6897 | Remote Similarity | NPC327579 |
0.6882 | Remote Similarity | NPC276373 |
0.6845 | Remote Similarity | NPC5802 |
0.6838 | Remote Similarity | NPC87981 |
0.6838 | Remote Similarity | NPC174114 |
0.6824 | Remote Similarity | NPC33382 |
0.6809 | Remote Similarity | NPC157821 |
0.6784 | Remote Similarity | NPC125659 |
0.6784 | Remote Similarity | NPC168702 |
0.6779 | Remote Similarity | NPC248007 |
0.6776 | Remote Similarity | NPC246193 |
0.6705 | Remote Similarity | NPC222174 |
0.6647 | Remote Similarity | NPC14590 |
0.6588 | Remote Similarity | NPC321393 |
0.6577 | Remote Similarity | NPC139776 |
0.6573 | Remote Similarity | NPC4837 |
0.6573 | Remote Similarity | NPC312187 |
0.6452 | Remote Similarity | NPC287876 |
0.6391 | Remote Similarity | NPC472834 |
0.6387 | Remote Similarity | NPC14330 |
0.6338 | Remote Similarity | NPC18335 |
0.6275 | Remote Similarity | NPC109322 |
0.6256 | Remote Similarity | NPC250178 |
0.62 | Remote Similarity | NPC189314 |
0.6099 | Remote Similarity | NPC164845 |
0.6093 | Remote Similarity | NPC68938 |
0.6084 | Remote Similarity | NPC217656 |
0.6048 | Remote Similarity | NPC89139 |
0.6048 | Remote Similarity | NPC107160 |
0.6041 | Remote Similarity | NPC103388 |
0.6038 | Remote Similarity | NPC160666 |
0.6037 | Remote Similarity | NPC296437 |
0.6 | Remote Similarity | NPC470266 |
0.6 | Remote Similarity | NPC313547 |
0.6 | Remote Similarity | NPC5707 |
0.5972 | Remote Similarity | NPC476561 |
0.5962 | Remote Similarity | NPC21461 |
0.5953 | Remote Similarity | NPC158055 |
0.5941 | Remote Similarity | NPC244700 |
0.5928 | Remote Similarity | NPC476528 |
0.5928 | Remote Similarity | NPC476433 |
0.5924 | Remote Similarity | NPC180493 |
0.5893 | Remote Similarity | NPC476013 |
0.5893 | Remote Similarity | NPC476522 |
0.5893 | Remote Similarity | NPC474986 |
0.5893 | Remote Similarity | NPC476520 |
0.5886 | Remote Similarity | NPC472833 |
0.5882 | Remote Similarity | NPC476408 |
0.5877 | Remote Similarity | NPC150447 |
0.5873 | Remote Similarity | NPC265111 |
0.5858 | Remote Similarity | NPC476521 |
0.585 | Remote Similarity | NPC119133 |
0.5829 | Remote Similarity | NPC473585 |
0.5787 | Remote Similarity | NPC472832 |
0.5787 | Remote Similarity | NPC18308 |
0.5782 | Remote Similarity | NPC476099 |
0.5689 | Remote Similarity | NPC324815 |
0.5676 | Remote Similarity | NPC476562 |
0.5621 | Remote Similarity | NPC256849 |
0.5621 | Remote Similarity | NPC41958 |
0.5619 | Remote Similarity | NPC315126 |
0.5619 | Remote Similarity | NPC314774 |
0.5616 | Remote Similarity | NPC293163 |
0.5608 | Remote Similarity | NPC59314 |
0.5608 | Remote Similarity | NPC10466 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC136349 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD548 | Clinical (unspecified phase) |
0.9067 | High Similarity | NPD1776 | Approved |
0.9067 | High Similarity | NPD1777 | Approved |
0.9007 | High Similarity | NPD250 | Approved |
0.9007 | High Similarity | NPD249 | Approved |
0.8881 | High Similarity | NPD186 | Discovery |
0.8881 | High Similarity | NPD195 | Approved |
0.8865 | High Similarity | NPD185 | Approved |
0.8741 | High Similarity | NPD166 | Approved |
0.8723 | High Similarity | NPD193 | Suspended |
0.8649 | High Similarity | NPD3107 | Discontinued |
0.8639 | High Similarity | NPD283 | Approved |
0.8608 | High Similarity | NPD1412 | Clinical (unspecified phase) |
0.8523 | High Similarity | NPD1369 | Phase 2 |
0.8523 | High Similarity | NPD338 | Approved |
0.8523 | High Similarity | NPD1750 | Clinical (unspecified phase) |
0.8523 | High Similarity | NPD242 | Approved |
0.8477 | Intermediate Similarity | NPD2646 | Discontinued |
0.8477 | Intermediate Similarity | NPD2624 | Phase 2 |
0.8467 | Intermediate Similarity | NPD339 | Approved |
0.8411 | Intermediate Similarity | NPD169 | Phase 2 |
0.8355 | Intermediate Similarity | NPD1732 | Phase 3 |
0.8345 | Intermediate Similarity | NPD248 | Discontinued |
0.8158 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.8158 | Intermediate Similarity | NPD214 | Approved |
0.8144 | Intermediate Similarity | NPD2632 | Approved |
0.8144 | Intermediate Similarity | NPD2630 | Approved |
0.8144 | Intermediate Similarity | NPD2631 | Clinical (unspecified phase) |
0.8133 | Intermediate Similarity | NPD6417 | Clinical (unspecified phase) |
0.8117 | Intermediate Similarity | NPD216 | Approved |
0.8117 | Intermediate Similarity | NPD220 | Clinical (unspecified phase) |
0.8117 | Intermediate Similarity | NPD218 | Approved |
0.8117 | Intermediate Similarity | NPD219 | Phase 3 |
0.8117 | Intermediate Similarity | NPD217 | Approved |
0.7937 | Intermediate Similarity | NPD2647 | Phase 3 |
0.7875 | Intermediate Similarity | NPD7988 | Suspended |
0.7817 | Intermediate Similarity | NPD870 | Clinical (unspecified phase) |
0.7805 | Intermediate Similarity | NPD5666 | Phase 2 |
0.7771 | Intermediate Similarity | NPD546 | Clinical (unspecified phase) |
0.7764 | Intermediate Similarity | NPD247 | Clinical (unspecified phase) |
0.7651 | Intermediate Similarity | NPD4171 | Clinical (unspecified phase) |
0.7639 | Intermediate Similarity | NPD9633 | Phase 3 |
0.7586 | Intermediate Similarity | NPD9632 | Phase 3 |
0.7578 | Intermediate Similarity | NPD3083 | Approved |
0.7516 | Intermediate Similarity | NPD516 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD7158 | Phase 1 |
0.7515 | Intermediate Similarity | NPD4716 | Approved |
0.7485 | Intermediate Similarity | NPD1692 | Approved |
0.7471 | Intermediate Similarity | NPD4744 | Clinical (unspecified phase) |
0.745 | Intermediate Similarity | NPD252 | Clinical (unspecified phase) |
0.7431 | Intermediate Similarity | NPD9408 | Phase 3 |
0.7399 | Intermediate Similarity | NPD5682 | Phase 3 |
0.7399 | Intermediate Similarity | NPD5683 | Clinical (unspecified phase) |
0.7399 | Intermediate Similarity | NPD5684 | Clinical (unspecified phase) |
0.7383 | Intermediate Similarity | NPD194 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD549 | Approved |
0.7219 | Intermediate Similarity | NPD4495 | Phase 1 |
0.717 | Intermediate Similarity | NPD3708 | Phase 2 |
0.7081 | Intermediate Similarity | NPD231 | Clinical (unspecified phase) |
0.7081 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD582 | Approved |
0.7032 | Intermediate Similarity | NPD3696 | Approved |
0.7032 | Intermediate Similarity | NPD3695 | Approved |
0.7022 | Intermediate Similarity | NPD207 | Discontinued |
0.6966 | Remote Similarity | NPD7138 | Phase 2 |
0.6944 | Remote Similarity | NPD9606 | Approved |
0.6897 | Remote Similarity | NPD9607 | Approved |
0.6863 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.6852 | Remote Similarity | NPD3085 | Phase 1 |
0.681 | Remote Similarity | NPD3086 | Phase 3 |
0.6796 | Remote Similarity | NPD4054 | Clinical (unspecified phase) |
0.6779 | Remote Similarity | NPD9084 | Phase 2 |
0.6772 | Remote Similarity | NPD2965 | Clinical (unspecified phase) |
0.6766 | Remote Similarity | NPD4074 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD171 | Discontinued |
0.6737 | Remote Similarity | NPD2876 | Phase 3 |
0.6737 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.6736 | Remote Similarity | NPD9374 | Approved |
0.6713 | Remote Similarity | NPD9373 | Approved |
0.671 | Remote Similarity | NPD9484 | Clinical (unspecified phase) |
0.6708 | Remote Similarity | NPD1730 | Discontinued |
0.6687 | Remote Similarity | NPD4240 | Approved |
0.6667 | Remote Similarity | NPD2824 | Phase 2 |
0.6667 | Remote Similarity | NPD307 | Approved |
0.6623 | Remote Similarity | NPD282 | Approved |
0.6573 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.6566 | Remote Similarity | NPD9605 | Phase 3 |
0.6538 | Remote Similarity | NPD1058 | Discontinued |
0.6538 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.6497 | Remote Similarity | NPD1119 | Phase 2 |
0.6463 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.646 | Remote Similarity | NPD1431 | Approved |
0.646 | Remote Similarity | NPD1430 | Approved |
0.6452 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.6447 | Remote Similarity | NPD2902 | Phase 2 |
0.6447 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.6416 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.6405 | Remote Similarity | NPD281 | Approved |
0.6395 | Remote Similarity | NPD9584 | Phase 2 |
0.638 | Remote Similarity | NPD9704 | Approved |
0.6375 | Remote Similarity | NPD799 | Phase 1 |
0.6369 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.6369 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.6359 | Remote Similarity | NPD1063 | Phase 2 |
0.6354 | Remote Similarity | NPD4458 | Phase 2 |
0.6354 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.6338 | Remote Similarity | NPD8836 | Approved |
0.6325 | Remote Similarity | NPD775 | Approved |
0.6323 | Remote Similarity | NPD1127 | Approved |
0.6323 | Remote Similarity | NPD1128 | Approved |
0.6258 | Remote Similarity | NPD2253 | Discontinued |
0.6213 | Remote Similarity | NPD353 | Discontinued |
0.6203 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.62 | Remote Similarity | NPD8833 | Approved |
0.62 | Remote Similarity | NPD8831 | Approved |
0.619 | Remote Similarity | NPD9375 | Discontinued |
0.6184 | Remote Similarity | NPD9409 | Discontinued |
0.6173 | Remote Similarity | NPD1808 | Phase 1 |
0.6171 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.6169 | Remote Similarity | NPD798 | Discontinued |
0.6158 | Remote Similarity | NPD5080 | Phase 2 |
0.6154 | Remote Similarity | NPD5486 | Discontinued |
0.6149 | Remote Similarity | NPD1121 | Approved |
0.6149 | Remote Similarity | NPD1120 | Approved |
0.6149 | Remote Similarity | NPD535 | Approved |
0.6138 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.6111 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.6111 | Remote Similarity | NPD6112 | Approved |
0.6108 | Remote Similarity | NPD5079 | Phase 2 |
0.6098 | Remote Similarity | NPD1118 | Discontinued |
0.6085 | Remote Similarity | NPD5627 | Approved |
0.6061 | Remote Similarity | NPD5458 | Discontinued |
0.6051 | Remote Similarity | NPD515 | Phase 1 |
0.6 | Remote Similarity | NPD8830 | Phase 3 |
0.5962 | Remote Similarity | NPD6381 | Phase 2 |
0.596 | Remote Similarity | NPD757 | Phase 3 |
0.5953 | Remote Similarity | NPD6840 | Approved |
0.5953 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.5948 | Remote Similarity | NPD9360 | Approved |
0.5946 | Remote Similarity | NPD5171 | Clinical (unspecified phase) |
0.5928 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.5924 | Remote Similarity | NPD9544 | Approved |
0.5924 | Remote Similarity | NPD78 | Approved |
0.5899 | Remote Similarity | NPD5768 | Phase 2 |
0.5862 | Remote Similarity | NPD6023 | Discontinued |
0.585 | Remote Similarity | NPD9291 | Approved |
0.5849 | Remote Similarity | NPD9696 | Approved |
0.5849 | Remote Similarity | NPD1775 | Approved |
0.5849 | Remote Similarity | NPD1085 | Approved |
0.5844 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.5838 | Remote Similarity | NPD7842 | Phase 2 |
0.5833 | Remote Similarity | NPD2221 | Clinical (unspecified phase) |
0.5779 | Remote Similarity | NPD1368 | Approved |
0.5778 | Remote Similarity | NPD1122 | Clinical (unspecified phase) |
0.5742 | Remote Similarity | NPD578 | Discontinued |
0.5714 | Remote Similarity | NPD796 | Phase 2 |
0.5706 | Remote Similarity | NPD1017 | Clinical (unspecified phase) |
0.5705 | Remote Similarity | NPD580 | Discontinued |
0.5689 | Remote Similarity | NPD8250 | Phase 2 |
0.5677 | Remote Similarity | NPD3913 | Clinical (unspecified phase) |
0.5667 | Remote Similarity | NPD9417 | Phase 3 |
0.5667 | Remote Similarity | NPD9416 | Phase 3 |
0.5645 | Remote Similarity | NPD4089 | Clinical (unspecified phase) |
0.564 | Remote Similarity | NPD4555 | Clinical (unspecified phase) |
0.5625 | Remote Similarity | NPD579 | Clinical (unspecified phase) |
0.5621 | Remote Similarity | NPD9358 | Approved |
0.5621 | Remote Similarity | NPD9359 | Approved |
0.5617 | Remote Similarity | NPD1355 | Clinical (unspecified phase) |
0.5617 | Remote Similarity | NPD1354 | Approved |
0.5617 | Remote Similarity | NPD1356 | Approved |
0.5608 | Remote Similarity | NPD8837 | Clinical (unspecified phase) |
0.5608 | Remote Similarity | NPD341 | Approved |
0.5608 | Remote Similarity | NPD340 | Approved |
0.5604 | Remote Similarity | NPD4143 | Clinical (unspecified phase) |
PubChem CID   | 439176 |
ChEMBL   | CHEMBL277041 |
ZINC   |
Molecular Weight:   | 297.09 |
ALogP:   | -1.1259 |
MLogP:   | 1.68 |
XLogP:   | -0.493 |
# Rotatable Bonds:   | 7 |
Polar Surface Area:   | 144.61 |
# H-Bond Aceptor:   | 8 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 20 |